Cargando…

Potential therapeutic target secretogranin II might cooperate with hypoxia‐inducible factor 1α in sunitinib‐resistant renal cell carcinoma

Multitargeted receptor tyrosine kinase inhibitors, including vascular endothelial growth factor (VEGF) inhibitors, such as sunitinib, have been used as the primary targeted agents for patients with recurrent or distant metastasis of advanced renal cell carcinoma (RCC). However, endogenous or acquire...

Descripción completa

Detalles Bibliográficos
Autores principales: Fukumoto, Wataru, Yoshino, Hirofumi, Horike, Shin‐Ichi, Kawakami, Issei, Tamai, Motoki, Arima, Junya, Kawahara, Ichiro, Mitsuke, Akihiko, Sakaguchi, Takashi, Inoguchi, Satoru, Meguro‐Horike, Makiko, Tatarano, Shuichi, Enokida, Hideki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10551594/
https://www.ncbi.nlm.nih.gov/pubmed/37545017
http://dx.doi.org/10.1111/cas.15914